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1. Introduction
1. 1. Wound healing 
Wound healing is a complex and well-orchestrated process, where numerous factors are activated or
inhibited in a sequence of steps. It is the process of restoration in injured skin tissue and one of the
most important therapeutic targets. Furthermore, it is an evolutionarily conserved, multi-cellular,
multi-molecular process involving co-ordinated inter-play between complex signaling networks. 
Immediately after the infliction of damage, the repair of wound starts (Kasuya & Tokura 2014). A
wound comprises a break in skin epithelial continuity and is characterized by disruption of structure
and function of underlying tissues. After injury, skin integrity must be restored promptly in order to
re-establish homeostatic mechanisms, prevent infection and minimize fluid loss. This is achieved
through a complex biological process where multiple parallel and interrelated pathways are
activated and synchronized to induce wound repair. Once complete, they must be shut down in a
precise order to prevent exaggerated or delayed responses (Greaves et al. 2013). 
As a normal biological process in the human body, wound healing is achieved through four
precisely and highly programmed overlapping phases: hemostasis, inflammatory phase,
proliferative phase, and tissue remodeling phase or restoration (Fig 1.). These phases and their bio-
physiological functions must occur in the proper sequence, at a specific time, and continue for a
specific duration at an optimal intensity. There are many factors that can affect wound healing
which interfere with one or more phases in this process, thus causing improper or impaired tissue
repair. 
Wounds that exhibit impaired healing, including delayed acute wounds and chronic wounds,
generally have failed to progress through the normal stages of healing. Such wounds are
characterized by a prolonged inflammation, persistent infections, formation of drug-resistant
microbial biofilms and the inability of dermal and/or epidermal cells to respond to regenerative
stimuli (Fromm-Dornieden & Koenen 2013). Most chronic wounds are ulcers that are associated
with ischemia, diabetes mellitus, venous stasis disease, or pressure (Guo & DiPetro 2010; Mathieu
et al. 2006). 
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Figure 1. Overview of overlapping 4-phase model of acute wound healing and its timeframe. Phase 1 – hemostasis. After cutaneous
injury vasoconstriction, clotting cascades and platelets act together to prevent prolonged hemorrhage. Once fibrin clot forms there is
vasodilation enabling PMN extravasation and migration to the wound site; phase 2 – inflammation. An initial influx of neutrophils is
later replaced by macrophages which have an early inflammatory (M1) and later reparative (M2) phenotype. There is phagocytosis of
bacteria and wound debris with concurrent secretion of multiple growth factors, chemokines and cytokines which drive fibroblast and
endothelial cell recruitment to the wound bed; phase 3 – cellular proliferation. Migratory endothelial cells and fibroblasts proliferate
resulting in ECM deposition, angiogenesis and granulation tissue formation. ECM forms a scaffold for further cellular influx and is
remodelled by a variety of enzymes so that its composition changes throughout wound healing; phase 4 – remodelling. Wound
maturation occurs with continued ECM remodelling into a predominantly collagenous structure, fibroblast differentiation into
myofibroblasts, wound contraction and gradually reducing cellularity with eventual scar formation. Re-epithelialisation occurs
concurrently beginning within hours of injury until there is restoration of epithelial continuity. PMN, polymorphonuclear cells; ECM,
extracellular matrix. Source: Greaves et al. 2013. 
1.1.1. Hemostasis
Hemostasis is an essential step for the initiation and continuation of the wound healing process and
is characterized by stopping of a flow of blood in the healing wound. It is well established that the
major stages of hemostasis are vasoconstriction, platelet degranulation and aggregation, and fibrin 
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deposition (Pakyari et al. 2013). Injury to damaged blood vessels stimulates the clotting cascade
resulting in proteolytic cleavage of fibrinogen by the enzyme thrombin and formation of an
insoluble fibrin clot (Diegelmann & Evans 2004). As the barrier function of the skin is
compromised at the wound site, the clot holds damaged tissues together and functions as a
temporary shield. Structurally, it provides a provisional matrix for cell migration (Clark 2001). The
first subset of cells that enter the injury site are platelets. Platelets release many different growth
factors and inflammatory cytokines, such as platelet-derived growth factor (PDGF), TGF-β1,
epidermal growth factor (EGF), and fibroblast growth factor (FGF), all of which promote the
inflammatory phase and some of which function as chemoattractants. 
1.1.2. Inflammatory phase
This phase is characterized by increased capillary permeability and cell migration into the wound
site. Vasodilation that follows the early vasoconstriction is the result of capillary leaks that are
mediated by histamine, leukotrienes, and prostaglandins (Richardson 2004). Neutrophils are among
the first cells infiltrating the wound site, followed by monocytes and lymphocytes (Zaja-Milatovic
& Richmond 2008). These proinflammatory cells are necessary to remove debris and kill bacteria
through phagocytosis and free radical production. Neutrophils have innate antimicrobial functions,
in addition to releasing proteases to eliminate the denatured ECM components. A critical function
of neutrophils is the clearance of invading microbes and cellular debris in the wound area.
Leukocyte migration into the injured tissue is mediated by factors such as TGF-β, PDGF, IL-1 and
many other cytokines and growth factors. Monocytes transform into macrophages as they enter the
wounded area under the influence of TGF-β, ECM, complement particles and serum factors.
Macrophages clear the area of debris and microbes and release many important cytokines and
factors, such as FGF, TGF-β, PDGF, and EGF, which in turn initiate the formation of granulation
tissue (Behm et al. 2012). Macrophages also act as antigen-presenting cells (Rennekampff et al.
2000). Macrophages even stimulate angiogenesis and fibroplasia and ECM production, thereby
linking between the inflammatory and proliferation phases. However, it is notable that excess
inflammation may delay the process of wound healing, because prolonged edema disturbs
progression to the next step, and pro-inflammatory cytokines and toxic free radicals are harmful for
skin constituents (Kasuya & Tokura 2014). 
As inflammatory phase declines, fewer inflammatory factors are secreted, existing ones are broken
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down, and remaining neutrophils and macrophages are reduced at the wound site. These changes
indicate that the inflammatory phase is ending and the proliferative phase is underway (Opalenik &
Davidson 2005). In vitro evidence, obtained using the dermal equivalent model, suggests that the
presence of macrophages actually delays wound contraction and thus the disappearance of
macrophages from the wound may be essential for subsequent phases to occur (Akasaka et al.
2004). 
Because inflammation plays roles in fighting infection, clearing debris and inducing the
proliferation phase, it is a necessary part of healing. However, inflammation can lead to tissue
damage if it lasts too long (Bayat et al. 2003). Thus the reduction of inflammation is frequently a
goal in therapeutic settings. Inflammation lasts as long as there is debris in the wound. Thus, if the
individual's immune system is compromised and is unable to clear the debris from the wound and/or
if excessive detritus, devitalized tissue or microbial biofilm is present in the wound, these factors
may cause a prolonged inflammatory phase and prevent the wound from properly commencing the
proliferation phase of healing. This can lead to a chronic wound.
1.1.3. Proliferative phase
Cellular proliferation represents the third phase of the 4-stage acute wound healing model.
Proliferation of cellular and structural components is triggered by factors secreted during the
preceding inflammatory phase. The main and leading events that happen during this phase include
re-epithelialization, angiogenesis, and fibroplasia. 
 It begins 3–4 days after injury and continues for 2–4 weeks. During this time there is fibroblast and
endothelial cell proliferation, phenotypic alteration and migration as well as ECM deposition, and
granulation tissue formation (Singer & Clark 1999; Bauer et al. 2005). Fibroblast derived ECM
provides support for further cellular influx, adhesion, and differentiation (Gurtner et al. 2008; Clark
2001). After its formation, ECM undergoes continuous synthesis and remodelling, reaching a steady
state 21 days after wounding (Diegelmann & Evans 2004). Initially disorganized fibrin is later
remodeled with hyaluronan, proteoglycans and fibronectin (FN) before a predominantly
collagenous final structure (mostly types I and III) is formed (Clark 2001; Welch et al. 1990; Clark
et al. 1995). Remodelling is achieved by specific matrix metalloproteins (MMPs) influenced by 
transforming growth factor-β (TGF-β), platelet derived growth factor (PDGF), interleukin-1 (IL-1)
and epidermal growth factor (EGF), which are tightly regulated. Blood vessel sprouts invade the
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wound concurrent with fibroblast in-growth. Neovascularization occurs in response to pro-
angiogenic factors including vascular endothelial growth factor (VEGF), fibroblast growth factor
(FGF), angiogenin, angiotropin, and angiopoietin-1 (Ang-1) released by infiltrating macrophages
and keratinocytes (Folkman & D‘Amore 1996; Iruela-Arispe & Dvorak 1997; Risau 1997). The
dense population of fibroblasts, macrophages and neovasculature, embedded within a loose matrix
of collagen, FN and hyaluronic acid is termed granulation tissue. It is a response to abundant growth
factors (GFs) and cytokines found in the wound from 4 days post-injury onwards (Diegelmann &
Evans 2004; Pilcher et al. 1999; Parks 1999). In later stages of the proliferative phase, fibroblasts
assume the myofibroblast (MF) phenotype which contains a-smooth muscle actin (aSMA) (Gurtner
et al. 2008; Opalenik & Davidson 2005). During fibroplasia, fibroblasts migrate, proliferate, and
produce ECM components, which result in formation of granulation tissue within the wound site.
Fibroblast migration is mediated by TGF-β1 and PDGF in this phase. 
Granulation tissue formation and fibroblast migration enable wound contraction from day 6 post
injury but is GF- dependent relying heavily on PDGF and TGF-β (Macri & Clark 2009; Greaves et
al 2013). Following robust proliferation and ECM synthesis, wound healing enters the final
remodelling phase, which can last for years. (Gosain & DiPietro 2004; Campos et al. 2008).
1.1.4. Remodelling phase
As the final phase of wound healing, the remodelling phase is responsible for the development of
new epithelium and final scar tissue formation. Synthesis of the extracellular matrix in the
proliferative and remodelling phases is initiated contemporarily with granulation tissue
development. This phase may last up to 1 or 2 years, or sometimes for an even more prolonged
period of time (Pilling et al. 2006; Ignos & Massague 1986). The remodelling of an acute wound is
tightly controlled by regulatory mechanisms with the aim of maintaining a delicate balance between
degradation and synthesis, leading to normal healing. Along with intracellular matrix maturation,
collagen bundles increase in diameter and hyaluronic acid and fibronectin are degraded (Garcia-de-
Alba et al. 2010; Tomasek et al. 2009). The tensile strength of the wound increases progressively in 
parallel with collagen collection (Tomasek et al. 2009; Hinz et al. 2001). Collagen fibers may regain
approximately 80% of the original strength compared with unwounded tissue. The acquired final
strength depends on the localization of the repair and its duration, but the original strength of the
5
tissue can never be regained (Singer & Clark 1999; Hinz et al. 2001).
Synthesis and breakdown of collagen as well as extracellular matrix remodelling take place
continuously and both tend to equilibrate to a steady state about 3 weeks after injury (Hartlapp et al.
2001; Hinz et al. 2001). Matrix metalloproteinase enzymes, produced by neutrophils, macrophages,
and fibroblasts in the wound, are responsible for the degradation of collagen. Their activity is
tightly regulated and synchronized by inhibitory factors. Gradually, the activity of tissue inhibitors
of metalloproteinases increases, culminating in a drop in activity of metalloproteinase enzymes,
thereby promoting new matrix accumulation (Iruela-Arispe et al. 1997; Hinz et al. 2001; Namiki et
al. 1995). 
Although the initial deposition of collagen bundles is highly disorganized, the new collagen matrix
becomes more oriented and cross-linked over time. Its subsequent organization is achieved during
the final stages of the remodelling phase, to a greater extent by the wound contraction that has
already begun in the proliferative phase. The underlying connective tissue shrinks in size and brings
the wound margins closer together, owing to fibroblast interactions with the extracellular matrix.
The process is regulated by a number of factors, with PDGF, TGF-β, and FGF being the most
important (Hinz et al. 2001; Monaco & Lawrence 2003). As the wound heals, the density of
fibroblasts and macrophages is further reduced by apoptosis (Ehrlich & Rajaratnam 1990; Ohtani et
al. 2007). With time, the growth of capillaries stops, blood flow to the area declines and metabolic
activity at the wound site decreases (Hinz et al. 2001; Stavri et al. 1995). The end result is a fully
matured scar with a decreased number of cells and blood vessels and a high tensile strength. 
1.2 Larvae 
Maggot (larval) therapy is highly successful in cleansing infected and necrotic wounds (Sherman et
al. 2000) and has been practiced since the 1930s when William Baer’s observations confirmed the
reduction of bacterial load at the wound site by the use of maggots (Baer 1931). The main actions of
fly maggots on wounds may be categorized into three modes: debridement, disinfection and
bacterial death, and stimulation of tissue granulation and repair. However, the use of maggot
therapy declined as antibiotics were developed and surgical techniques improved. Nevertheless,
new strains of pathogenic fungi and bacteria developed primarily in response to overdose usage of
antibiotics and thus were found commonly in hospitals and the wider community (Kerridge et al.
2005), renewing the interest in maggot therapy in the search for effective methods to treat non-
healing wounds and control the evolution of resistance (Bexfield et al. 2004). Recently, several
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studies reporting antimicrobial activity of the hemolymph and maggot extract, either in the whole
body or in the excreta/secreta, have provided impetus for the development of alternative
antimicrobial products into therapeutically valuable anti-infective agents. It is well known that
insects have a well-developed innate immune system, subdivided into cellular and humoral defense
responses, the latter of which involve production of antimicrobial peptides (AMPs) that are
synthesized in the fat body and subsequently secreted into the hemolymph (Bulet et al.1999;
Hoffmann & Reichhart 2002). 
1.2.1 Hermetia illucens larvae
The larvae of the black soldier fly, Hermetia illucens, are scavengers that can live in extremely
harsh environments, such as manures and compost, inhabited by bacteria and fungi. The torpedo-
shaped larvae  can grow up to 27 mm in length and about 6 mm in width (Diclaro & Kaufman 2009;
Tomberlin et al. 2001).
Animal wastes and rotten plants can be decomposed and recycled by larvae. Additionally, the black
soldier fly is sometimes found in carrion. These biological characteristics suggest that the soldier fly
may be rich in different types of AMPs and other substances possessing activity against drug-
resistant “superbugs”. Recently, the antibacterial effect of H. illucens larval extract against Gram-
negative bacteria was evaluated (Choi e t a l . 2012). However, insects infected with the
microorganism could contain more biologically and pharmacologically active chemicals and
evidence has been reported that antibacterial activity of the extract from induced larvae was much
stronger than that of native larvae (Hou et al. 2007). The aim of the present study is to get
antimicrobial substances from H. llucens larvae and to test antibacterial activity of its extracts
against a range of Gram-positive and Gram-negative bacteria.
1.2.2 Antimicrobial substances in larvae
Antimicrobial peptides have been shown to be an crucial component of the insect’s innate defense
system, giving powerful resistance to a broad range of harmful parasites and pathogens (Boman.
1995; 2000). The majority of those identified have been shown to be inducible, low molecular
weight, cationic peptides (Bulet et al. 1999). Seven different families of antimicrobial peptides have
been described in insects: attacins, cecropins, defensin, diptericins, drosocin, drosomycins and
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metchnikowin. Attacins, diptericins and drosocin are active against Gram-negative, while defensin
against Gram-positive bacteria. Drosomycins are antifungal peptides, whereas cecropins and
metchnikowin exert antibacterial as well as antifungal activity (Hoffmann and Reichhart. 2002;
Hultmark. 2003; Tzou et al. 2002;  Uvell and Engström. 2007). Among them are members of linear
α-helical peptides (cecropins and moricin-like peptides), cysteine-stabilized peptides (defensins),
proline-rich peptides, and glycine-rich peptides (gloverin). An important role in insect humoral
immune response against pathogens is also played by lysozyme, constitutively present in the
hemolymph (Hultmark. 1996; Yu et al. 2002). Moreover, it was shown that bacterial cells became
more susceptible to antimicrobial peptides in the presence of lysozyme, and such synergistic action
of lysozyme with cecropin B, attacin and defensin, against Escherichia coli was demonstrated
(Chalk et al. 1994; Engström et al. 1984).
Figure 2. Hermetia illucens (Black soldier fly)A) adult (photography); B) larvae (photography);
Source: Schmelzer & Gurib-Fakim, 2013.
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1.3. Aims and objectives
The aim of this study was to evaluate an extract from insect Hermetia illucens (Black soldier fly),
larvae for their influence on wound healing process in vitro. Concentration was on inflammatory
phase of wound healing process because of well known anti-microbial properties of Black soldier
fly larvae. For this purpose, methanol extracts as well as chloroform and ethyl acetate extracts of the
larvae and different fractions of those extracts would be examined on four different bacterial species
which include Gram-positive and Gram-negative bacteria.Four different bacterial species are:
Escherichia coli BL21 (DE3), Micrococcus luteus, Pseudomonas fluorescens BL915 and Bacillus
subtilis.  The principal investigation method would be bacterial growth assay where inhibition of
bacterial growth will be examined. Furthermore, cytotoxicity of three main extract phases  would be
verified using Neutral Red assay on HepG2 and NHDF cell lines.
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2. Materials and methods
2.1.Materials
2.1.1. Chemicals
 Table 1.  List of used chemicals                
Chemical Manufacturer
Acetic acid Roth, Karlsruhe (D) 
Bacto tryptone Roth, Karlsruhe (D) 
Chloramphenicol AppliChem, Darmstadt (D) 
Chloroform Roth, Karlsruhe (D) 
Dimethyl sulfoxide (DMSO) Roth, Karlsruhe (D) 
Ethyl acetate Roth, Karlsruhe (D) 
Ethylenediamine tetraacetate (EDTA) Roth, Karlsruhe (D) 
Ethanol Roth, Karlsruhe (D) 
Non-essential amino acids Biochrom, Berlin (D)
Glucose Roth, Karlsruhe (D) 
Glycerin AppliChem, Darmstadt (D) 
Yeast extract Roth, Karlsruhe (D) 
Methanol VWR Pro Labo Chemicals, Darmstadt (D) 
Sodium chloride Roth, Karlsruhe (D) 
Gentamicin Biochrom, Berlin (D)
Peptone Roth, Karlsruhe (D) 
Trypsin/EDTA Solution Biochrom, Berlin (D)
Hank´s salt solution Biochrom, Berlin (D)
RPMI 1640 Media Biochrom, Berlin (D)
Dulbecco´s MEM Media Biochrom, Berlin (D)
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FBS TU Dresden, Dresden (D)
Neutral red powder Sigma-Aldrich, St. Louis (USA)
Isopropyl alcohol Roth, Karlsruhe (D)
TriFast PeqLab, Erlangen (D)
5x GoTaq Flexi reaction buffer Promega, Madison (USA)
Magnesium chloride Roth, Karlsruhe (D)
Diethyl pyrocarbonate (DEPC) Sigma-Aldrich, St. Louis (USA)
DNase I Fermentas, Toronto (CA)
RevertAid Reverse Transcriptase Thermo Fisher Scientific, Waltham (USA)
Sodium hydroxide Roth, Karlsruhe (D)
Hydrogen chloride Roth, Karlsruhe (D)
2.1.2. Devices
Table 2.  Equipment with the associated manufacturing firms 
Equipment Manufacturer
Stickmixer OPTIPRO 600 W Moulinex, Alencon (FRA) 
Ultrospec 2000 spectrophotometer Pharmacia Biotech, Uppsala (SWE) 
Vacuum rotary evaporator Buchi, Essen (D) 
Centrifuge Avanti J-26 XP Backman Coulter, Brea (USA) 
Centrifuge Universal 30F Hettich, Tuttlingen (D) 
NanoDrop 1000 spectrophotometer Thermo Scientific
Microplate Reader Infinite F200 Tecan
Analysis software NanoDrop 1000 Thermo Scientific
 Inverted microscope ID03 Carl Zeiss, (D)
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CO2 incubator Sanyo
Centrifuge 1-14 (bench centrifuge) Sigma-Aldrich, Steinheim (D) 
Analysis software Magellan Tecan
Refrigerated Centrifuge 5702R Eppendorf
Sterile filter Eppendorf
syringe Eppendorf
2.1.3 Microorganisms  used 
Table 3. Microorganisms used  with short name and origin
Strain Short term Reference / origin 
Escherichia coli  BL21 (DE3) E. coli Invitrogen, Carlsbad (USA) 
Micrococcus luteus M. luteus Strain Collection AG Gutzeit,
TU Dresden 
Pseudomonas f luorescens
BL915 
P. fluorescens HILL et al. 1994 
Bacillus subtilis B. subtilis DSMZ, Braunschweig (D) 
2.1.4 Cell lines
Two human cell lines (TU Dresden) were used in this study; human hepatocellular carcinoma
(HepG2) and normal human dermal fibroblasts (NHDF) . The HepG2 cells are epithelial carcinoma
cells derived from the liver (ATCC, 2004). NHDF are derived from the dermis of normal human
neonatal foreskin or adult skin.
2.1.5 Media and antibiotics 
For the cultivation and killing of the microorganisms below listed media and antibiotic were used.
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To adjust the pH of media NaOH or HCl was used. For sterilization the culture media were
autoclaved for 20 min at 121°C. 
LB medium (Sambrook & Russell 2001) 
10 g                   NaCl
10 g                   Bacto tryptone
5 g                     Yeast extract
1 L                     H2O
pH was adjusted to 7.4 before autoclaving
RPMI 1640 Media supplemented with Gentamicin and FBS
500 mL              RPMI 1640 Media
5 mL                  Gentamicin
50 mL                FBS
Gentamicin and FBS were mixed together in sterile beaker and then sterilized through sterile filter
into bottle with RPMI 1640 Media
Dulbecco´s MEM Media supplemented with Gentamicin, FBS and non-essential amino acids
500 mL             Dulbecco´s MEM Media
5 mL                 Gentamicin
100 mL             FBS
5 mL                 non-essential amino acids
Gentamicin, FBS  and non-essential amino acids were mixed together in sterile beaker and then
sterilized through sterile filter into bottle with  Dulbecco´s MEM Media
Chloramphenicol stock solution ( c= 10 mg/mL)
50 mg                 solid chloramphenicol
5 mL                   96% Ethanol
Chloramphenicol used for bacterial growth assay (c= 2.88 mg/mL,V= 10 mL)
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2.88 mL             chloramphenicol stock solution 
7.12 mL             distilled H2O
2.2 Methods
2.2.1 Storage of microorganisms
For long-term storage of bacterial cultures sterile glycerol cultures of created strains, whose
retention was carried out at –80°C, were used. 
2.2.2 Cultivation of microorganisms
2.2.2.1 Cultivation of Escherichia coli
The cultivation was carried out in liquid cultures in LB medium in 13 x 100 mm borosilicate glass
culture/test tubes with caps. 10 μL of Escherichia coli BL21 (DE3) from glycerol culture was
inoculated into 4 mL of LB media and left incubating and shaking over night on 30°C and 180 rpm.
 2.2.2.2 Cultivation of Micrococcus luteus
The cultivation was carried out in liquid cultures in LB medium in 13 x 100 mm borosilicate glass
culture/test tubes with caps. 10 μL of M. luteus  from glycerol culture was inoculated into 4 mL of
LB media and left incubating and shaking over/night on 30°C and 180 rpm.
2.2.2.3 Cultivation of Pseudomonas fluorescens
The cultivation was carried out in liquid cultures in LB medium in 13 x 100 mm borosilicate glass
culture/test tubes with caps. 10  μL of P. fluorescens BL915  from glycerol culture was inoculated
into 4 mL of LB media and left incubating and shaking over/night on 30°C and 180 rpm.
2.2.2.4 Cultivation of  Bacillus subtilis
The cultivation was carried out in liquid cultures in LB medium in 13 x 100 mm borosilicate glass
culture/test tubes with caps. 10  μL of B. subtilis  from glycerol culture was inoculated into 4 mL of
LB media and left incubating and shaking over/night on 30°C and 180 rpm.
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2.2.3 Raising of Hermetia illucens 
2.2.3.1 Breeding 
The breeding of Hermetia illucens is carried out in a separate breeding station. The breeding
facility is located on the site of a Biogas plant in Grimma, near Leipzig, Germany. In the breeding
system feeding the larvae was carried out with shredded food waste (non-vegetarian) of different
compositions. The larvae were transported in the plastic boxes or plastic bags, partly with small
amounts of already implemented substrate, partly without substrate, from the breeding station and
further cultured in the laboratory. There was the need for a regular replenishment of larvae, as in the
laboratory no established breeding was present. 
2.2.3.2 Keeping the larvae in the laboratory 
The larvae were kept in standard plastic boxes. Several hundreds grams of larvae were held in large
boxes (30 x 20 x 20 cm). All boxes were provided with air holes and with a commercial insect net
to prevent an exodus of larvae. 
The larvae were always stored in the incubator at 26°C during the cultivation time. The optimum
temperature for culturing Hermetia illucens is between 27°C and 30°C (Tomberlin et al. 2009). 
2.2.3.3 Feeding of larvae 
All the larvae were fed with regular larval food which contain: corn, wheat, soy extract, calcium
carbonate, sunflower extract, wheat bran, distilled grains and vegetable fatty acids. Additionally,
larvae were fed with organic waste because it is hypothesized that it would activate greater
production of anti-microbial substances within the larvae compared to larvae fed with regular food. 
2.2.3.4 Killing of larvae 
After collection of the larvae from the food they were washed using a commercial kitchen sieve
under cold water to remove food residues and after short drying on paper towels transferred to
plastic bags. The killing of the larvae was carried out by cold, the larvae were frozen at -196°C in
liquid nitrogen . The larvae were kept at -20°C in  freezer. 
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2.2.4 Extraction of larvae
2.2.4.1 Mixing and centrifuging 
Frozen larvae were taken out of the freezer and thawed at the room temperature for three hours.
Larvae were weighed and the weigh of thawed larvae was: m (thawed larval population)= 818 g.
After that, larvae have been transferred into eight 1L sterile beakers and in each sterile beaker
contained m=125.25 g of larvae.  Larvae in each sterile beaker were poured with 258.3 mL of
methanol, 25.83 mL of distilled water and 2.87 mL of acetic acid. All this components were mixed
with hand mixer until  all larvae smashed  into small pieces so there was no whole larvae. Duration
of mixing procedure was about five minutes. Then, all sterile beakers with larval mixture were
covered with aluminum foil and left on stirrer over night. Next morning, larval mixtures from eight
sterile beakers were transferred to centrifugation tubes (Volume of each centrifugation tube was 500
mL) and centrifuged on 6681 x g; 20°C for 15 minutes. After centrifugation of larval mixtures,
supernatant was decanted from centrifugation tubes to two round bottom flasks.
Same extraction procedures as above were used to prepare extracts of larvae fed with organic waste.
Extracts were also prepared from feces of larvae fed with organic waste since it is well known that
majority of important antimicrobial compounds  which larvae possess could be found in larval gut.
2.2.4.2 Concentrating of larval extracts
Larval mixtures in round bottom flasks (which were decanted after centrifugation) were evaporated
in vacuum rotary evaporator under reduced pressure. Half of round bottom flask with larval
mixtures was sank into warm bath (on 40°C) while it was rotating at the same time on vacuum
rotary evaporator. Pressure starting point on the beginning of the procedure of concentrating of the
larval extracts was 240 mbar and it was slowly decreased until 100 mbar. Process of  evaporation
was carried out for roughly two hours. In this procedure methanol was fully evaporated and leftover
liquid ( which contained larval extracts) was used for further purification and extraction.
2.2.4.3 Separating funnel extraction
Concentrated leftover liquid (extract; which was concentrated on the rotary evaporator) was
transferred to a separating funnel. After that, 50 mL of chloroform was added to separating funnel
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and whole mixture was shaken while separating funnel was closed to prevent leakage of content.
Then, separating funnel was turned upside down and tap was opened to release the gas which
accumulated after shaking. After approximately three minutes of incubation, two phases appeared in
separating funnel: upper- which was aqueous phase and lower which was chloroform phase. Lower
chloroform phase was let to flow through into Claissen dish by opening the tap on the separating
funnel. To aqueous phase, which was still in the separating funnel, 50 mL of ethyl acetate was
added and the whole procedure was repeated:  separating funnel was turned upside down and tap
was opened to release the gas which accumulated after shaking. After approximately three minutes
of incubation two phases appeared in separating funnel: upper- which was now ethyl acetate phase
and lower- which was aqueous phase. Each of these two phases (ethyl acetate and aqueous phase)
were carefully let to flow through to two different  Claissen dishes.
For all three phases which were separated on separating funnel concentrating on rotary evaporator
was conducted: Half of round bottom flask with larval mixtures was sank into warm bath (at 40°C)
while it was rotating at the same time on vacuum rotary evaporator. Pressure starting point on the
beginning of the procedure of concentrating of the chloroform phase was 400 mbar and it was
slowly decreased until 300 mbar. Pressure starting point on the beginning of the procedure of
concentrating of the ethyl acetate phase was 200 mbar and it was slowly decreased until 150 mbar.
Pressure starting point on the beginning of the procedure of concentrating of the aqueous phase was
300 mbar and it was slowly decreased until approximately 40 mbar.
All three extract  phases (aqueous, ethyl acetate and chloroform) were kept in fridge at 4°C and
were used for further experiments such as bacterial growth assay and cell toxicity tests.
2.2.5 Bacterial growth assay
2.2.5.1 Measuring of the OD of bacteria
Fifty mL of E. coli bacteria was added to plastic cuvette and mixed with 950 mL of LB medium, it
was thoroughly resuspended pippeting several times up and down. Same procedure was used for
other three bacterial species: M. luteus, P. fluorescens and B. subtilis in three different cuvettes.
Nine hundred fifty mL of LB medium was also added to one separate cuvette. Then, the OD was
determined on spectrophotometer at 600 nm. First, OD was measured for LB medium only and that
value was used as a reference for measurement of OD of bacterial species. After that, OD was
measured for each of four bacterial species. Measured values were used to calculate the volume of
each of bacteria and LB medium that should be used in order to get the OD= 0.05 which was later
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on used  in bacterial growth assay. To calculate the volumes of each bacteria following formula was
used:
                                                              Vfinal=  OD  final   x  V 1
                                                                          ODmeasured
where Vfinal is volume of bacteria that should be mixed with LB medium subtracted by the same
number in order to get OD=0.05 of bacteria, ODfinal is 0.05,  V1 is always 50mL and ODmeasured is
measured OD.
When final volumes for each of bacteria were calculated, they were used to prepare mixture of
bacteria and LB medium for all of four different bacterial species in four different  Eppendorf tubes
in order to be used in bacterial growth assay.
2.2.5.2 Preparation of master mix tubes
For each of 4 bacterial species 8 different Eppendorf tubes with master mixes were prepared. 
In following scheme volumes of used substances in general master mix preparation for  E. coli
bacteria used in bacterial growth assay  is showed:
Negative control 
225 μL                  distilled H2O
25 μL                    peptone                             300 μL
50 μL                    E. coli, OD= 0.05
Positive control  
175 μL                 distilled H2O
25 μL                   peptone                                                             300 μL
50 μL                   E. coli, OD= 0.05
50 μL                   chloramphenicol, c= 2.88 mg/mL   
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6 different Eppendorf tubes with different dilutions of different  Hermetia llucens extracts
175 μL                 distilled H2O
25 μL                   peptone                                                         300 μL in each of six Eppendorf  tubes
50 μL                   E. coli, OD= 0.05
50 μL                   of different extracts in each tube  
5 0 μL of extract in each tube actually serves as a substitute for antibiotic, and its antimicrobial
activity is measured.
Same procedure is repeated with all of  the three bacterial species left: M. luteus, P. fluorescens and
B. subtilis. After preparation of master mix tubes there was 32 master mix tubes  which were used
in preparation of the 96-well plate for bacterial growth assay.
2.2.5.3 Plate preparation
For 96-well preparation 32 master mix tubes with bacteria, antibiotic, extracts and negative controls
were used.
For each sample in plate preparation three repetitions (three wells of 96-well plate) were used and
following pipetting order (Table 1.) was applied: 1 . E. coli- growth control (negative control)
------antibiotic  control (positive control)                extract 1.          …           extract 6.
60 μL of each sample was pipetted in each well of the 96-well plate.
Table 3.Pipetting scheme on the 96-well plate for bacterial growth assay
1 2 3 4 5 6 7 8 9 10 11 12
A E.coli-
negative
control,
60 μL
E.coli-
e x t r a c t l ,
60 μL
E.coli-
e x t r a c t 4 ,
60 μL
M.luteus-
negative
control,
60 μL
M.luteus-
extract  l,
60 μL
M.luteus-
extract  4,
60 μL
P.fluorescen
s-negative
control,
60 μL
P.fluorescen
s- extract  1,
60 μL
P.fluorescen
s- extract  4,,
60 μL
B.subtilis-
negative
control,
60 μL
B.subtilis-
extract  l,
60 μL
B.subtilis-
extract  4,
60 μL
B E.coli-
negative
control,
60 μL
E.coli-
extract  2,
60 μL
E.coli-
e x t r a c t 4 ,
60 μL
M.luteus-
negative
control,
60 μL
M.luteus-
extract  2,
60 μL
M.luteus-
extract  4,
60 μL
P.fluorescen
s-negative
control,
60 μL
P.fluorescen
s- extract  2,
60 μL
P.fluorescen
s- extract  4,
60 μL
B.subtilis-
negative
control,
60 μL
B.subtilis-
extract  2,
60 μL
B.subtilis-
extract  4,
60 μL
C E.coli-
negative
control,
60 μL
E.coli-
extract  2,
60 μL
E.coli-
extract  5.
60 μL
M.luteus-
negative
control,
60 μL
M.luteus-
extract  2,
60 μL
M.luteus-
extract  5,
60 μL
P.fluorescen
s-negative
control,
60 μL
P.fluorescen
s- extract  2,
60 μL
P.fluorescen
s- extract  5,
60 μL
B.subtilis-
negative
control,
60 μL
B.subtilis-
extract  2,
60 μL
B.subtilis-
extract  5,
60 μL
D E.coli-
positive
E.coli-
extract  2,
E.coli-
extract  5,
M.luteus-
positive
M.luteus-
extract   2,
M.luteus-
extract  5,
P.fluorescen
s-  positive
P.fluorescen
s- extract  2,
P.fluorescen
s- extract  5,
B.subtilis-
positive
B.subtilis-
extract  2,
B.subtilis-
extract  5,
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control,
60 μL
60 μL 60 μL, control,
60 μL
60 μL 60 μL control,
60 μL
60 μL 60 μL control,
60 μL
60 μL, 60 μL
E E.coli-
positive
control,
60 μL
E.coli-
extract  3,
60 μL
E.coli-
extract  5,
60 μL
M.luteus-
positive
control,
60 μL
M.luteus-
extract  3,
60 μL
M.luteus-
extract  5,
60 μL
P.fluorescen
s-  positive
control,
60 μL
P.fluorescen
s- extract  3,
60 μL
P.fluorescen
s- extract  5,
60 μL
B.subtilis-
positive
control,
60 μL
B.subtilis-
extract  3,
60 μL
B.subtilis-
extract  5,
60 μL
F E.coli-
positive
control,
60 μL
E.coli-
extract  3,
60 μL
E.coli-
extract  6,
60 μL
M.luteus-
positive
control,
60 μL
M.luteus-
extract  3,
60 μL
M.luteus-
extract  6,
60 μL
P.fluorescen
s-  positive
control,
60 μL
P.fluorescen
s- extract  3,
60 μL
P.fluorescen
s- extract  6,
60 μL
B.subtilis-
positive
control,
60 μL
B.subtilis-
extract  3,
60 μL
B.subtilis-
extract  6,
60 μL
G E.coli-
extract  l,
60 μL
E.coli-
extract  3,
60 μL
E.coli-
extract  6,
60 μL
M.luteus-
extract  l,
60 μL
M.luteus-
extract  3,
60 μL
M.luteus-
extract  6,
60 μL
P.fluorescen
s- extract  1,
60 μL
P.fluorescen
s- extract  3,
60 μL
P.fluorescen
s- extract  6,
60 μL
B.subtilis-
extract  l,
60 μL
B.subtilis-
extract  3,
60 μL
B.subtilis-
extract  6,
60 μL
H E.coli-
extract  l,
60 μL
E.coli-
extract  4,
60 μL
E.coli-
e x t r a c t 6 ,
60 μL
M.luteus-
extract  l,
60 μL
M.luteus-
extract  4,
60 μL
M.luteus-
extract  6,
60 μL
P.fluorescen
s- extract  1,
60 μL
P.fluorescen
s- extract  4,
60 μL
P.fluorescen
s- extract  6,
60 μL
B.subtilis-
extract  l,
60 μL
B.subtilis-
extract  4,
60 μL
B.subtilis-
extract  6,
60 μL
After preparation of 96-well plate it have been put to Tecan Infinite 200 spectrophotometer.
Spectrophotometer parameters were then set up to 25 kinetic cycles with an interval time of one
hour per kinetic cycle. Through this 25 cycles absorbance was measured on 600 nm. 
After 24 hours of plate reading in the spectrophotometer plate was taken out and discarded into
toxic waste bin and measured data was evaluated.
Bacterial growth assay was set up every day throughout the period of time of two months.
Sometimes, same samples were prepared for several times since bacteria in control wells did not
grow or some of the wells were contaminated. 
2.2.6 Cell culture
2.2.6.1 Cells storage
The HepG2 and NHDF cells which have been used in this research had previously been stored by
freezing in liquid nitrogen.
2.2.6.2 HepG2 and NHDF cells cultivation
Cell aliquots of HepG2 and NHDF cell lines were taken out from cryogenic tank and warmed up at
room temperature until they were completely thawed. Aliquots were then transferred into centrifuge
tubes and 10 ml of selective culture media was added to it. For cultivation of HepG2 cells RPMI
1640 Media supplemented with Gentamicin and FBS was used and for cultivation of  NHDF cells
Dulbecco´s MEM Media supplemented with Gentamicin, FBS and non-essential amino acids was
used. Then, cells were centrifuged at 100 x g on room temperature  (20°C) for 5 minutes. After
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centrifugation, supernatant was discarded while pellet was resuspended in 1 ml selective media.
From such cells/media suspension two aliquots of 500 μL  were taken and transferred to two 75
cm2 cell culture flasks. Following that, 20 mL of selective media was added to each flask and flasks
with cells were put to incubator. Incubator temperature was 37°C  with a humidified atmosphere of
5% CO2  in air.
All the used growth media were stored in refrigerator at 4°C and prior to use were warmed shortly
in a water bath at 37°C.
2.2.6.3 HepG2 and NHDF cell line splitting
When approximately 80%  confluency had been reached, which was after seven days of incubating,
cells were split (i.e., subcultured).
Firstly,  old medium was removed by using sterile glass pipette and cells were rinsed with 10 ml of
Hank´s salt solution (i.e.,PBS). After that, PBS was taken out and 1 mL of PBS and 1 mL of 10x
Trypsin/EDTA was added and cells were incubated in incubator for five minutes. Following
incubation, cells were observed under the microscope to check if most of the cells had detached. In
some cases, only small amount of cells had detached, so the incubation was extended for two
minutes which resulted in larger amount of detached cells. After that, detachment of the cells was
stopped by addition of 10 mL of growth medium. The cell suspension was then transferred into 15
ml centrifuge tube and centrifuged at 100 x g at room temperature  (20°C) for 5 minutes. Following
centrifugation, supernatant was discarded while pellet was resuspended in 1 ml growth medium.
From both centrifuged cell cultures (HepG2 and NHDF) 10 μL of cell suspension was transferred
into a Neubauer counting chamber and cells were counted. The appropriate amount of thus obtained
cell suspension was then transferred into 75 cm2 cell culture flasks and 20 mL of culture medium
was added. Cells were passaged in 1/8 ratio and it took 7 days to reach appropriate confluency for
both cell cultures.
2.2.7 Neutral Red assay
This method is based upon protocol of Borenfreund and Puerner, 1985. The uptake of the vital dye
Neutral Red into the lysosomes/endosomes and vacuoles of living cells is used as a quantitative
indication of cell number and viability. This protocol was used for both cell lines; HepG2 and
NHDF.
First, cell suspension of  1x105 per mL in culture medium was prepared in a sterile reservoir for
multi-channel pipette. Using a multi-channel pipette  100 μL of cell suspension was dispensed into
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wells of first eleven columns of 96-well tissue culture microtiter plate (=  1x104 cells per well), last
column was left empty for subsequent blank measurement. Prepared 96-well plates were left in
incubator in order to establish confluency in each well of 96-well plate where cells were dispensed.
After incubation time of three days, pre-prepared dilutions of Hermetia illucens extracts were added
to each well which contained cells. Extracts were prepared by dilution of extracts obtained by
separating funnel extraction in sterile media which was used for cell culture. For control of non-
toxic activity water diluted in growth media was used and it was pipetted into first column of each
plate. Extracts were added  by pipetting  100 μL of diluted extract to wells of 96-well plate which
already contained 100  μL  media. Then, whole content in each well was resuspended by going up
and down with pipette several times, and finally  100  μL of that content was taken out with pipette
and transferred to waste while volume in each well was still  100  μL. After extracts addition to
each plate, plates were incubated for various periods of times. Standard times used for incubation of
extracts with cells were 4 hours and 24 hours. 
After incubation of extracts whole content of each plate was discarded into waste (while cells were
still attached to the bottom surface of each well) and each well was washed two times by adding
200 μL of Hank´s salt solution. After washing, 100 μL of Neutral Red dye was added to wells of
first eleven columns of the 96-well plate. After that, plates were put to incubator for incubation for
three hours. After that, Neutral Red dye was discarded and 100 μL of lysis buffer was added to each
well in the 96-well plate. After waiting period of fifteen minutes absorbance was measured  using
Ultrospec 2000 spectrophotometer and obtained data was evaluated.
Neutral red assay was also used in testing toxicity of control substance with both HepG2 and NHDF
cells. Control substance was Pentabromopseudilin which was known for its cytotoxicity. Dilutions
of Pentabromopseudilin were prepared by diluting the substance in DMSO. Also, DMSO diluted in
PBS was used as a control for non-toxic activity.
2.2.8 Statistical analysis
All measurements were performed at least in triplicates and the results were expressed as mean
value ± standard deviation (SD). Calculation of mean values and standard deviation was preformed
using Open Office software.
Statistical analysis, which involved one-way ANOVA and Tukey´s test, was carried out using
Origin software in order to deduce statistical significance of the acquired results. Mean values of
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three independent experiments were used and the results were considered relative to control (H2O) .
An obtained p-value ≤ 0.05 (*) was considered significant, while p-values  ≤ 0.01 (**) and p ≤
0.001 (***) were considered as highly significant.
3. Results
First, three phases of extracts were applied to E. coli bacteria and bacterial growth inhibition  was
measured using bacterial growth assay during period of 19 hours (Fig. 3).
Figure 3. Effects of three different regular food fed Hermetia illucnes larvae extracts on growth inhibition of E.
coli bacteria during 19 hours.
Dark blue curve represents negative control (dH2O) for growth inhibition of E. coli bacteria where none of the extracts were applied.
Orange curve represents positive control for growth inhibition of E. coli bacteria where chloramphenicol antibiotic was applied in the
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concentration of c=2.88 mg/mL. Yellow and light blue curves represent growth inhibition of E. coli bacteria where H2O phases of
Hermetia illucens extracts were applied in different  dilutions of 1:100 and 1:200 respectively. Medium green and  darkest green
curves  represent growth inhibition of E. coli bacteria where CHCl3 phases of Hermetia illucens extracts were applied in different
dilutions of 1:100 and 1:200 respectively. Red and lightest green curves represent growth inhibition of E. coli bacteria where EtOAc
phases of Hermetia illucens extracts were applied in different  dilutions of 1:100 and 1:200 respectively. Data of three independent
experiments are  expressed as the mean ± standard error. 
As seen in figure 3. growth curve of E. coli bacteria during period of 19 hours, when none of the
extracts  were applied, is consistent with exponential growth and thus could be described as normal
bacterial growth. For negative control, instead of any extracts, distilled water was used together
with other substances essential for bacterial growth. As expected, growth of bacteria was
completely inhibited in presence of antibiotic Chloramfenicol (c=2.88 mg/mL) which was used as
positive control. When H2O phase extract was applied in higher dilution of 1:200 to E. coli bacteria
growth was not inhibited and the growth curve was as same as negative control. Lower dilution (i.e.
higher concentration) of the same H2O phase extract of 1:100 showed significant inhibition during
first 14 hours of measurement  and remarkable inhibition in the next 5 hours when compared to
lower concentrated sample. Moreover, there was no inhibition of E. coli growth when CHCl3 phase
extract was applied in higher dilution of 1:200 and there was just minimal inhibition when same
extract was applied in higher concentration. EtOAc phase extract applied to E. coli  bacteria
preformed impressive inhibition in lower dilution of 1:100 and it was as same as antibiotic control.
Lower concentration of the same extract also had an inhibitory effect which was approximately in
between of positive and negative controls.
It is known (Steiner et al. 1981) that insects have a well-developed innate immune system which
involves production of anti-microbial peptides. Those AMPs are synthesized in the fat body and
later on secreted into the hemolymph of an insect (Bulet et al. 1999; Hoffmann & Reichhart 2002).
Accordingly, Hermetia illucens larvae extracts were applied to both Gram-negative and Gram-
positive bacteria, the latter of which were also included in this research (Fig. 4., Fig. 5.)
Figure 4. shows influence of three different extracts  in two dilutions of Hermetia illucnes larvae on
growth inhibition of M. luteus bacteria. Again, distilled water and chloramphenicol antibiotic were
used as negative and positive control respectively. Aqueous phase of the extract applied to M.
luteus bacteria in both dilutions of 1:100 and 1:200 showed inhibiting influence on bacterial growth
but still not as inhibitory as antibiotic did. Furthermore, growth of the same bacteria when
chloroform phase extracts were applied showed even greater inhibition. Interestingly, this phase did
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not show any notable difference when applied in two different dilutions. Once more, ethyl acetate
phase extract exhibited remarkable inhibition when applied to M. luteus bacteria. Both dilutions
(1:100 and 1:200) of the ethyl acetate phase displayed similar outcome and it was as same as
antibiotic control. 
Figure 4. Effects of three different regular food fed Hermetia illucnes larvae extracts on growth inhibition of M.
luteus bacteria during 14 hours.
Dark blue curve represents negative control (dH2O) for growth inhibition of M. luteus bacteria where none of the extracts were
applied. Orange curve represents positive control for growth inhibition of M. luteus bacteria where chloramphenicol antibiotic was
applied in the concentration of c=2,88 mg/mL. Yellow and light blue curves represent growth inhibition of M. luteus bacteria where
H2O phases of Hermetia illucens extracts were applied in different dilutions of 1:100 and 1:200 respectively. Medium green and
darkest green curves represent growth inhibition of M. luteus bacteria where CHCl3 phases of Hermetia illucens extracts were
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applied in different dilutions of 1:100 and 1:200 respectively. Red and lightest green curves represent growth inhibition of M. luteus
bacteria where EtOAc phase of Hermetia illucens extract were applied in different  dilutions of 1:100 and 1:200 respectively. Data
of three independent experiments are expressed as the mean ± standard error. 
The next step was to look at the influence of the same extracts in same dilutions on another Gram-
positive bacteria, Bacillus subtilis (Figure 5.).
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Figure 5. Effects of three different regular food fed Hermetia illucnes larvae extracts on growth inhibition of B.
subtilis bacteria during 19 hours.
Dark blue curve represents negative control (dH2O) for growth inhibition of B. subtilis bacteria where none of the extracts were
applied. Orange curve represents positive control for growth inhibition of B. subtilis bacteria where chloramphenicol antibiotic was
applied. Yellow and light blue curves represent growth inhibition of B. subtilis bacteria where H2O phases of Hermetia illucens
extracts were applied in different dilutions of 1:100 and 1:200 respectively. Medium green and  darkest green curves  represent
growth inhibition of B. subtilis bacteria where CHCl3 phases of Hermetia illucens extracts were applied in different  dilutions of
1:100 and 1:200 respectively. Red and lightest green curves represent growth inhibition of B. subtilis bacteria where EtOAc phases of
Hermetia illucens extracts were applied in different  dilutions of 1:100 and 1:200 respectively. Data of three independent experiments
are expressed as the mean ± standard error. 
It could be observed that when same extracts were applied to B. subtilis bacteria they preformed
impressive inhibition (Figure 5.). Chloroform and ethyl acetate phase in both dilutions were as
inhibiting as positive control. While, H2O phase in higher dilution showed growth delay during first
eleven hours of measurement and after that time point bacteria starts to grow but it is still quite
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inhibited. Lower dilution of the same phase showed even more delayed growth which lasts during
first fifteen hours of measurement. 
Finally, all the extracts were applied to P. fluorescens bacteria in order to identify their anti-
microbial properties on another Gram-negative bacteria (Figure 6.). 
Figure 6. Effects of three different regular food fed  Hermetia illucens larvae extracts on growth inhibition of P.
fluorescens  bacteria during 19 hours.
Dark blue curve represents negative control (dH2O) for growth inhibition of P. fluorescens bacteria where none of the extracts were
applied. Orange curve represents positive control for growth inhibition of P. fluorescens bacteria where chloramphenicol antibiotic
was applied. Yellow and light blue curves represent growth inhibition of P. fluorescens bacteria where H2O phases of Hermetia
illucens extracts were applied in different dilutions of 1:100 and 1:200 respectively. Medium green and  darkest green curves
represent growth inhibition of P. fluorescens bacteria where CHCl3 phases of Hermetia illucens extracts were applied in different
dilutions of 1:100 and 1:200 respectively. Red and lightest green curves represent growth inhibition of P. fluorescens bacteria where
28
P. fluorescens
P. fluorescens + Cml (c=2.88 mg/mL)
P. fluorescenss + H
2
O phase 1:100 
P. fluorescens + CHCl
3
 phase 1:200
P. fluorescens + EtOAc phase 1:200
P. fluorescens + H
2
O phase 1:200
P. fluorescens + CHCl
3
 phase 1:100
P. fluorescens+ EtOAc phase 1:100
EtOAc phases of Hermetia illucens extracts were applied in different  dilutions of 1:100 and 1:200 respectively. Data of three
independent experiments are expressed as the mean ± standard error. 
In Figure 6. growth of P. fluorescens bacteria with different compounds applied was shown and it
could be seen that all three different phases of Hermetia illucens extracts preformed striking growth
inhibition. All the extracts showed reduced bacterial growth which is consistent with antibiotic
control except chloroform and aqueous phase in higher dilution. Bacteria with chloroform phase put
on in higher dilution exhibited  delayed growth during first 7 hours of growth monitoring after
which it starts to grow but still not as bacteria alone. When H2O phase was applied to bacteria in
lower concentration it started to grow slightly, although just in last three hours of measurement and
in much lower manner than negative control.
In Figure 7. influence of both extracts, from larvae fed with organic waste and from larval faeces
after application to afore mentioned bacterial species, is depicted .
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Figure 7. Effects of  different Hermetia illucens larvae and larval faeces extracts on growth inhibition of E. coli
bacteria during 14 hours.
Dark blue curve represents negative control (dH2O) for growth inhibition of E. coli bacteria where none of the extracts were applied.
Orange curve represents positive control for growth inhibition of E. coli bacteria where chloramphenicol antibiotic was applied.
Yellow curve represents growth inhibition of E. coli bacteria where H2O phases of Hermetia illucens organic waste fed larvae
extract was applied in dilution of 1:250. Medium green curve represents growth inhibition of E. coli bacteria where CHCl3 phase of
Hermetia illucens organic waste fed larvae extract was applied in dilution of 1:250. Red curve represents growth inhibition of E. coli
bacteria where EtOAc phase of Hermetia illucens organic waste fed larvae extract was applied in dilution of 1:250. Light blue curve
represents growth inhibition of E. coli bacteria where H2O phase of Hermetia illucens organic waste fed larvae´s feces extract was
applied in dilution of 1:1000. Dark green curve represents growth inhibition of E. coli bacteria where CHCl3 phase of Hermetia
illucens organic waste fed larvae´s feces extract was applied in dilution of 1:1000. Light green curve represents growth inhibition of
E. coli bacteria where EtOAc phase of Hermetia illucens organic waste fed larvae´s feces extract was applied in dilution of 1:1000.
Data of three independent experiments are expressed as the mean ± standard error. 
As seen in Figure 7. E. coli bacteria without any extracts or antibiotics applied grows exponentially
while on the other hand same bacteria with antibiotic added displays no growth. When larvae fed
with organic waste in H2O and EtOAc extracts were applied growth was completely inhibited while
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CHCl3 extract of the same larvae shows inhibition half way in between of positive and negative
control. Moreover, organic waste fed larvae´s feces applied in all three phases (H2O, CHCl3 and
EtOAC) in dilution of 1:1000 perform complete inhibition which are in line with the positive
control.
Except of testing the antimicrobial properties and potential of Hermetia illucens larvae´s extracts
their cytotoxic effects on human cells was assessed using Neutral Red assay. That is of certain
importance before any further investigation of mechanisms of action of these substances and before
investing in their development as a pharmaceutical for  wound healing.
Figures 8.-11. display cytotoxic effects of different Hermetia illucens  larvae extracts when applied
to human cells (HepG2 and NHDF) in vitro and their viability potential.
                A
               B
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Figure 8. Effect of Hermetia illucens  normal fed larvae H2O phase extract and its different dilutions on the cell
viability determined by Neutral Red assay in HepG2 cells during 4 hours (A) and 24 hours (B) 
Data of three independent experiments are represented relative to the H2O control (100%) and expressed as the mean ± standard
error. Each treatment group was performed in triplicates. Statistical significance is indicated relative to H2O control as * p ≤ 0,05, **
p≤  0,01,*** p≤  0,001 and it was calculated using  one-way ANOVA and Tukey´s test
Cytotoxicity of Hermetia illucens normal fed larvae  extract  was tested, when HepG2 cells were
incubated with H2O phase extract for four (Figure 8. A) and 24 hours (Figure 8. B),  by Neutral Red
assay and the results are presented in Figure 8. Treatment included H2O phase extract and different
dilutions of the same extract from 1:20 to 1:400. Some of the dilutions used in this experiment were
also used for bacterial growth assay. Control used was water mixed in ratio 1:20 with cell culture
media. After dilution of 1:120 non of the higher dilutions show cytotoxic effect. Furthermore, when
the extract was incubated with the cells for 24 hours, least diluted extracts, as expected,  showed
significant cytotoxicity and the first dilution which shows non-toxic influence is 1:140, while
dilutions of 1:100 and 1:120 show minor toxic effect.
Next, cytotoxicity of Hermetia illucens normal fed larvae CHCl3 phase extract  was tested, after
incubation with HepG2 cells for four and 24 hours (Figure 9.)
When the CHCl3 phase extract was applied to HepG2 cells (Figure 9.), different dilutions of extract
were used when compared to previous phase extract in Figure 8. This was done for experimental
convenience because every phase of the three different Hermetia illucens extracts needed to be
filtered through a syringe filter in order to be sterilized. Since that the CHCl3 phase extract, after the
evaporation on the rotary evaporator, was filled with lots of solids and was quite dense it needed to
be diluted with sterile water to be suitable for filtering through syringe filter. As a consequence, 1
mL of the CHCl3 phase extract was diluted in 2 mL of sterile water. After that different dilutions, of
already diluted extract, were prepared and they were applied to cells. Starting dilution was 1:60 and
the final, out of  20 dilutions, was 1:1200. Again, some of the dilutions used in this experiments
were already used for bacterial growth inhibition in the bacterial growth assay. Starting dilution of
the CHCl3 phase extract showed just slight cytotoxicity and the cell viability compared to control
was around 90 percent for both time points. First concentration which didn´t display any cytotoxic
effect on the cells was 1:540 and it was same for both 4 hours and 24 hours. All of the different
dilutions of the CHCl3 phase extract did not show any significant cytotoxic effect neither during 4
hours nor during 24 hours of incubation with HepG2 cells.
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Figure 9. Effect of Hermetia illucens  normal fed larvae CHCl3 phase extract and its different dilutions on the cell
viability determined by Neutral Red assay in HepG2 cells during 4 hours (A) and 24 hours (B) 
Data of three independent experiments are represented relative to the H2O control (100%) and expressed as the mean ± standard
error. Each treatment group was performed in triplicates. Statistical significance is indicated relative to H2O control as * p ≤ 0,05, **
p≤  0,01,*** p≤  0,001 and it was calculated using  one-way ANOVA and Tukey´s test
Cytotoxic effects of Hermetia illucens normal fed larvae EtOAc phase extract  were examined after
incubation with HepG2 cells for four and 24 hours (Figure 10.) Again, EtOAc phase extract was
also diluted prior to making serial dilutions for application to the HepG2 cells and it was for the
same reason as pervious phase extract. First couple of dilutions (1:60,1:120) of this phase of extract
applied to HepG2 cells showed cytotoxicity of 80% compared to control and it was the case in 4
hour and 24 hour incubation experiments. Subsequent dilutions showed decreased toxic effects
which was about 90%. First extract which was consistent with control  was 1:780 for 4 hours and
1:600 for 24 hours of incubation. It is important to notice that some of the upcoming dilutions,
which were after first non-toxic dilutions,  showed toxic result even though they were less
concentrated. 
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Figure 10. Effect of Hermetia illucens  normal fed larvae EtOAc phase extract and its different dilutions on the
cell viability determined by Neutral Red assay in HepG2 cells during 4 hours (A) and 24 hours (B). Data of three
independent experiments are represented relative to the H2O control (100%) and expressed as the mean ± standard error. Each
treatment group was performed in triplicates. Statistical significance is indicated relative to H2O control as * p ≤ 0,05, ** p≤
0,01,*** p≤  0,001 and it was calculated using  one-way ANOVA and Tukey´s test
Viability of the NHDF cells after the application of different phases of Hermetia illucens extracts
was also analyzed using the Neutral Red toxicity assay. NHDF cells are human dermal fibroblast
cells and in this project they should have been model for testing the effects of the extracts on the
expression of different molecular markers characteristic for the wound healing process. In order to
proceed with that cytotoxicity was assessed. 
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Figure 11. Effect of Hermetia illucens  normal fed larvae H2O phase extract and its different dilutions on the cell
viability determined by Neutral Red assay in NHDF cells during 24 hours. Data of three independent experiments are
represented relative to the H2O control (100%) and expressed as the mean ± standard error. Each treatment group was performed in
triplicates. Statistical significance is indicated relative to H2O control as * p ≤ 0,05, ** p≤  0,01,*** p≤  0,001 and it was calculated
using  one-way ANOVA and Tukey´s test
Figure 11. displays behavior of the NHDF when normal fed Hermetia illucens larvae H2O phase
extract was applied in the different dilutions starting form 1:20 and ending with the 1:400 dilution.
First three dilutions (1:20, 1:40, 1:60) of this extract show significant toxicity on the cells and it is
for all the three dilutions around 50 % when compared to control. Following four dilutions (1:80-
1:140) showed less toxic effects on the cells. Finally, first dilution which does not show cytotoxic
influence on the NHDF cells is 1:160 and all the next dilutions afterwards did not show any
cytotoxic impact.
Also, two other phases (CHCl3 and EtOAc) of Hermetia illucens extract  were tested for their
cytotoxicity effects on the NHDF cells and the results were in line with the results for the same
phases on HepG2 cells.
35
4. Discussion
4.1.Examination of antimicrobial potential of Hermetia illucens larvae extracts 
In this study, Hermetia illucens larvae extract, and its different phases in different concentrations
were evaluated for antimicrobial properties and that was first of two main goals of this research. It
is well known that the larvae of black soldier fly, Hermetia illucens, exist in harsh surroundings,
proposing that the soldier fly may be rich in generations of AMPs and similar substances possessing
activity against microorganisms, including MRSA (Choi et al. 2012).
Second goal of this project was to determine the effect of the same extracts on the human cells in
vitro and to test their cytotoxic properties.
The acidic methanol extraction protocol was used for the extraction of antimicrobial substances
from the larvae, since the acidic methanol can precipitate and denature large polypeptides and
proteins, and at the same time, efficiently extract small peptides such as AMPs. (Meylears et al.
2002). The acidic methanol extract of the larvae was sequentially extracted with chloroform and
ethyl acetate to remove lipids and to get the high density of anti-microbial substances. 
Aqueous phase of the normal fed Hermetia illucens larvae extract, which was actually concentrated
leftover liquid after evaporation of the methanol on the rotary evaporator, contained all of the
antimicrobial substances which inhibit bacterial growth. For that reason, aqueous phase (H2O)
extract preformed a broad-spectrum antimicrobial activity against a range of Gram-positive and
Gram-negative bacteria. H2O phase extract applied to E. coli bacteria (Figure 3.) showed dilution-
dependent growth manner. Dilution of 1:200 of this extract did not show any inhibiting properties
on the growth of E. coli bacteria but dilution of 1:100 showed the inhibiting effect which was
almost as good as  positive control. It has been previously reported that an extract of another larvae
species, housefly (Musca domestica), also showed antibacterial effects against E. coli and other
Gram-negative bacteria (Hou et al. 2007). While the H2O phase in higher dilution applied to  E. coli
bacteria had a minimal inhibitory effect on the growth of bacteria, same phase applied to another
Gram-negative bacteria, P. fluorescens, inhibited its growth even more (Figure 6.). Both dilutions of
H2O phase extract applied to P. fluorescens bacteria, that of 1:100 and 1:200, inhibited its growth
completely and the effect was comparable to the antibiotic control. 
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On the other hand, Gram-positive bacteria, or sometimes referred as Gram-variable bacteria , M.
luteus, displayed interesting results when treated with H2O phase extract. Higher dilution of 1:200
applied to this bacteria showed inhibiting properties and growth was delayed at the beginning of the
measurement, while the less diluted extract ( i.e. more concentrated) that of 1:100, showed better
growth of bacteria, especially during the first hours of measurement. Interestingly, in the couple of
the last hours of growth measurement of M. luteus, H2O phase extract in dilution of 1:100 starts to
display better inhibiting effects than the 1:200 dilution of the same extract. This variability, when
the more concentrated extract showed less potent inhibiting outcome probably lies in the
morphology of the the cell wall of the specific bacteria and on other bacterial mechanisms which
can affect influence of anti-microbial substances (Madigan & Martinko, 2005). 
This results, however, should be interpreted with caution since statistical analysis has not been
made for this particular set of the data, so experimental error should be considered.
Another Gram-positive bacteria, B. subtilis, treated with the H2O phase extract showed inhibiting
growth in the both dilutions of the H2O phase extract. Also, results were, as expected,
concentration-wise, meaning that higher concentration had a larger effect on bacterial growth.
When the results of the Gram-negative and Gram-positive bacteria for the H2O phase extract are
compared it could be seen that Gram-negative bacteria show slightly more sensitive effect when
treated with this phase of extract. This observation is not completely in accordance with the results
from other researches, but also on another species of larvae (Musca domestica), which reported that
their larvae extracts showed higher antibacterial activity against Gram-positive bacteria than against
Gram-negative bacteria (Hou et al. 2007). Also, it has been stated that the difference in
susceptibility between Gram-negative and Gram-positive bacteria might be explained by the
variations in morphological constitutions between these microorganisms. Gram-negative bacteria
have an outer phospholipidic membrane comprising lipopolysaccharide components, on the
contrary, the Gram-positive bacteria only have an external peptidoglycan layer which is not as an
successful permeability barricade as the previous (Nostro et al., 2000).
However, results from this study show that Gram-negative bacteria are slightly more susceptible to
larvae extracts, contrary to other published results, which is most likely due to the different species
of larvae used in this research. 
Since the aqueous (H2O phase), used in bacterial killing assays, was used as a phase which
contained majority of the AMPs, it is strongly believed that most of the anti-bacterial effects in the
bacterial killing assays belong to efficient performance of AMPs. AMPs consist of 12-50 amino
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acids and are capable of killing broad range of  pathogens (Zasloff, 2002). These peptides are
heterogenous group of molecules, showing high diversity in structure as well as speed and strategy
of killing microbes.  Furthermore, they are all of amphipathic and cationic nature, which is optimal
for bacterial killing and increases solubility, and thus bioavailability, in aqueous body fluids like
blood, urine and saliva. The positive charge allows the peptides to selectively bind to the bacterial
membrane by electrostatic interaction with compounds like lipopolysaccharide (LPS, Gram-
negative), phospholipids, lipoteichoic acid (LTA, Gram-positive) and peptidoglycans. Thereafter,
the amphipathic nature allows them to incorporate into the lipid bilayer of the bacterial surface,
which destroys the integrity of the bacterial membrane and the membrane potential thus ultimately
results in bacterial lysis and killing (Yeaman & Yount, 2003). 
Hermetia illucens larvae may be rich in different types of AMPs, as it is a case with other similar
insect species such as Lucilia sericata. These types include: members of the attacin,
cecropin/cecropin-like, defensins, diptericins, and proline-rich peptide families. Attacins were first
discovered in the silk moth Hyalophora cecropia and subsequently also in several Diptera. They are
characterized by a molecular mass of 20 to 25 kDa, with a high glycine residue content (Hultmark
et al. 1983). Attacins are active against some Gram-negative bacteria and were shown to inhibit the
synthesis of outer bacterial membrane proteins (Carlsson et al. 1991). The cecropin family of
peptides comprises linear amphipathic AMPs with an α-helical structure lacking cysteine residues.
The first cecropin was discovered in the silk moth H. cecropia (Steiner et al. 1981). They are
primarily active against Gram-negative bacteria but show moderate activities toward Gram-positive
bacteria, which is consistent with results in this study. Defensins are cationic AMPs with six
conserved cysteine residues that form three disulfide bonds. They comprise an amphipathic α-helix,
an antiparallel β-sheet, and an N-terminal loop and form voltage-dependent channels (Bonmatin et
al. 1992). The majority of the defensins are strongly expressed in the salivary glands of larvae, and
most of them are active against M. luteus bacteria. Recently lucifensin, a novel larval defensin, has
been identified as one of the antibacterial agents of medicinal maggots involved in MDT (maggot
debridement therapy). Lucifensin was shown to be constitutively produced in the salivary glands of
all larval stages during feeding. An infectious environment could induce its production in the fat
body from where lucifensin is secreted solely into the haemolymph. Lucifensin possesses
antibacterial activity against Gram-positive bacteria, most notably Streptococcus spp. and
Staphylococcus spp., but it fails to inhibit the growth of E. coli and P. aeruginosa (Jasenak et al.
2013.)
 Diptericins represent a multigene family of closely related inducible antibacterial peptides and are 
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produced in the fat body of the larvae (Reichhart et al. 1989). Proline-rich peptides are linear
molecules that consist of 14 to 39 amino acid residues, of which >25% are proline, often arranged
in triplets with basic residues, like arginine and histidine. Most proline-rich AMPs act selectively
against Gram-negative bacteria but have little impact on Gram-positive bacteria (Bulet & Stöcklin
2005). 
Since the ethyl acetate and chloroform phases also inhibited bacterial growth (Figures 3.-7.),  it is
strongly believed that this phases have other anti-bacterial compounds different than AMPs. It has
been previously reported that the whole-body extracts and haemolymph fractions from non-sterile
maggots contain low molecular weight compounds which can lyse Gram-positive and Gram-
negative bacteria including P. aeruginosa, K. pneumoniae and MRSA isolated from wounds. These
low molecular weight compounds were identified as p-hydroxybenzoic acid (138 Da), p-
hydroxyphenylacetic acid (152 Da) and octahydro-dipyrrolo[1,2-a;1',2'-d] pyrazine-5,10-dione (194
Da), also known as the cyclic dimer of proline (or proline diketopiperazine or cyclo[Pro,Pro])
(Huberman et al. 2007). 
From the biotechnological and clinical points of view, the molecules with low molecular weight are
more interesting due to their easier production, thermal and chemical stability and penetration
properties. Novel antibacterial molecules with low molecular weight have been identified (Nigam et
al. 2010). 
 One of them is seraticin, which is registered as a novel antibiotic  able to inhibit 12 different strains
of MRSA, as well as E. coli and C. difficile (Bexfield et al. 2008).
Since it has been shown previously that seraticin kills E. coli bacteria  it could be concluded that
this compound could be present in ethyl acetate phase of Hermetia illucens extract which showed
killing of E. coli (Figure 3.). Less diluted ethyl acetate extract showed complete inhibition of
bacterial growth while the more diluted sample showed less but still significant inhibition. On the
other hand, chloroform phase did not show such inhibiting effect on the E. coli so it is probably
absent of seraticin compound (Figure 3.). 
Furthermore, when Hermetia illucens organic waste fed larvae extracts and organic waste fed larvae
faeces extracts were applied in dilution of 1:250 and 1:1000 respectively, they showed even greater
inhibiting effect in all three phases than the normal fed larvae. Possible cause of the stronger anti-
bacterial effect of these extracts is that the food, which possibly contains parasites such as bacteria,
fungi or viruses could induce immunoreaction in the larvae which can lead to the greater and more
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concentrated production of anti-microbial compounds within the larvae. Interesting fact is that the 
feces extracts from Hermetia illucens organic waste fed larvae showed strong inhibiting effect in
high dilutions such as 1:1000 which can lend support to the further concentration of the researches
to go in that direction.
Moreover, it has been shown that septically injured larvae with a bacteria-contaminated needle after
extraction shows stronger anti-bacterial effect than the non infected larvae. 
Further investigation and research in the matter of getting more effective anti-microbial substances
would go in direction of purification of the different phases of extracts to get pure antimicrobials.
Park et al. used water-soluble fraction of the larval extract which was applied to Sep-Pak C18
cartridges, and eluted with each 20 mL of 10%, 20%, 30%, 50%, and 80% ACN. Antibacterial
activities of the Sep-Pak C18 eluants were measured by inhibition zone assay against MRSA, E.
coli, and B. subtilis. Significant anti-MRSA activity was observed at the fraction eluted with 10%
ACN. Also, purification of the extracts can include different methods such as HPLC.
4.2. Cytotoxicity assay 
In order to understand the characteristic of the cytotoxicity effect of Hermetia illucens larvae extract
on human cells, two cells lines were selected to be investigated throughout this study; HepG2 and
NHDF. As a class of drugs, antimicrobials are particularly troublesome with regard to cytotoxicity,
as their significant role is to ultimately achieve microbial cell death (Mandell et al. 2001). For
example, some antimicrobial peptides may provide benefit at lower antimicrobially active
concentrations with regard to prevention of infected wounds; however, at higher concentrations
they may exhibit cytotoxicity that might adversely affect wound healing (Chalekson et al. 2003).
Antiseptic agents whose main mechanism of action is the targeting of membranes pose problems for
therapeutic use in that they will exert a detergent-like effect, compromising both microbial and
mammalian cell membranes due to antimicrobial and cytotoxic effects (Duc et al. 2007). Cationic
antimicrobial peptides have been shown to exert their antimicrobial effect by selective
permeabilization of predominantly negatively charged bacterial membranes (Laverty et al. 2011).
However, just like antimicrobial action, cytotoxicity may be produced by a multitude of
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mechanisms. The treatment of cells at toxic concentrations can result in loss of membrane integrity
and cell lysis, with resulting leakage of cytoplasmic cell contents, in a process termed necrosis.
Alternatively the compound may invoke genetically programmed cell death, called apoptosis, where
cells stop actively dividing and therefore growing (Wyllie et al. 1980).
Aqueous phase of the Hermetia illucens larvae extract showed stronger cytotoxic effect, compared
to both chloroform and ethyl acetate phase, when applied to HepG2 and NHDF cells respectively
(Figures 8.-11.). It suggests that the main cytotoxic effects on the cells are actually caused by AMPs
since it is known that H2O phase,compared to other two phases, should contain most of the AMPs.
Cytotoxicity followed dose dependent manner so that the less diluted phase of extract showed
stronger toxic effect on the cells. 
4.3. Future prospects of Hermetia illucens extracts regarding wound healing
Next steps of the research with Hermetia illucens larvae extracts would include application of all of
the phases of extracts to NHDF cells in vitro and monitoring of the changes in expression of the
molecular markers of wound healing. Since it is well known that MDT improves wound healing
significantly when live larvae are applied to non-healing wounds it would be fair to expect that
extracts would increase expression of different proteins which drive wound healing process. Also,
extracts could be tested alone with the RT-PCR to quantify if they consist growth factors or other
molecules which could improve wound healing.
Since the wound healing process includes repair and restoration in the affected tissue and also scar
formation and finally wound closure, keratinocyte migration could be measured after application of
extracts. Most likely, extract treated keratinocytes or fibroblasts would show faster migration and
scar closure compared to mock treated cells but further experiments needs to be done. 
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5. Conclusion
For centuries, larvae were known to have beneficial effects on wounds. One of the ‘old’ techniques
in wound care is maggot debridement therapy (MDT). In MDT, live and ‘medical-grade’ fly larvae
are applied to the patient's wounds to achieve debridement, disinfection, and, ultimately, wound
healing. MDT is indicated for open wounds and ulcers that contain gangrenous or necrotic tissues
with infection.
This study has investigated Hermetia illucens larvae extracts influence on the disinfection step in
the wound healing process. Different phases of the extracts were applied to four bacterial species
and it was shown that they had a capacity of growth inhibition. Different phases have different
substances which can inhibit bacterial growth and therefore they showed varying magnitude in
inhibiting bacterial growth. Aqueous phase of the extract possibly contains AMPs which can inhibit
bacterial growth. Chloroform and ethyl acetate very likely have other anti-microbial substances
such as large anti-bacterial proteins and divergent derivatives of benzoic acid which also posses
capacity for bacterial  elimination. Bacterial growth inhibition was efficient with dilutions starting
from 1:100 and going up to more diluted 1:200 (most potent when applied to P. fluorescens bacteria
in all phases), but some of the dilutions showed efficacy in very high dilutions of 1:1000 ( H2O
phase organic waste fed larvae´s feces applied to E. coli)
Furthermore, extracts applied to human cells in different concentration showed toxicity just in
highest concentrations. In addition to that, most of the extracts in two concentrations used to kill
bacteria did not show cytotoxic effects on human cells. This results are consistent in both human
cell lines tested.
The emerging roll out of antibiotic resistant bacteria (specifically K. pneumoniae and MRSA) in
combination with the lack of new antibiotics means new strategies to treat resistant bacteria are
urgently needed, especially in treatment of non healing wounds. Major advantage in Hermetia
illucens extracts killing approach of bacteria, in contrast to traditional antibiotics, is the fact that
several effector systems will be activated simultaneously (different AMPs, larger antimicrobial
proteins and benzoic acid derivatives). This will practically make it impossible for bacteria to
develop resistance and will consequently improve disinfection of wounds and the wound healing
process in general.
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